Blocknomi
Key Highlights RVMD shares climbed approximately 38–40% during premarket hours Monday, reaching roughly $134 per share Daraxonrasib Phase 3 data revealed median overall survival of 13.2 months compared to 6.7…
Related articles
-
Saylor teases 'bigger' BTC buy days after floating semi-monthly dividends
Cointelegraph Published 20.04.2026 06:49
-
Dogecoin Price Prediction Targets $0.32 While AlphaPepe AI-DEX Demo Goes Live and Presale Nears $1M
Blocknomi Published 15.04.2026 21:00
-
With no bipartisan leadership, CFTC won't ‘slow down‘ on rulemaking
Cointelegraph Published 16.04.2026 17:52
-
Best Crypto to Buy Now: Pepeto Goes Viral as One Presale Draws the Capital That BlackRock Just Validated With $269 Million
BlockchainReporter Published 14.04.2026 20:30
-
Stock Futures Decline as US-Iran Conflict Intensifies Over Hormuz Strait
Blocknomi Published 20.04.2026 12:13
-
US should scrap crypto capital gains tax to fuel competition: Cato
Cointelegraph Published 16.04.2026 06:30
-
2026's biggest crypto exploit: $292 million gets drained from Kelp DAO with wrapped ether stranded across 20 chains
CoinDesk Published 18.04.2026 20:53
-
Samsung Electronics Faces Major Strike Threat as 40,000 Employees Protest Compensation Disparity
Blocknomi Published 23.04.2026 08:54